Molecular Analysis of KCNQ1, KCNH2 and SCN5A Genes in Iranian Patients with Long QT Syndrome
Received Date: Aug 10, 2018 / Accepted Date: Aug 21, 2018 / Published Date: Aug 24, 2018
Keywords: Long QT syndrome, Cardiac repolarization, Genetics; De novo mutation, Iran
Hereditary long QT syndrome (hLQTS) is one of the most prevalent causes of sudden cardiac death usually in the young people characterized by an abnormality in cardiac repolarization . LQTS can exist either as an autosomal dominant (Romano Ward syndrome, RW, MIM# 192500) or autosomal recessive (Jervel and Lange- Nielsen syndrome, JLNS, MIM# 220400) disorder. Both syndromes lead to recurrent syncope and prolongation of the QT interval in the electrocardiogram (ECG) . In addition to these symptoms JLNS patients suffer from sensorineural deafness . Mutations in sixteen genes encoding cardiac ion channels and associated proteins have so far been identified as responsible for all genotype-positive LQTS [4,5]. KCNQ1 (also known as KVLQT1) and KCNH2 (also known as human ether-a-go-go-related gene, HERG) are the two most common LQTS genes that mutations in which account for approximately 95% of cases . In this report, four patients with LQTS were analyzed to identify the mutations present in the three most common LQTS genes: KCNQ1, KCNH2 and SCN5A.
Materials and Methods
For further clinical assessments, four unrelated LQTS families were referred to the emergency unit at the Rajaei Cardiovascular Medical and Research Center, Tehran, Iran.
Family 1 (RW): The family study was conducted using three members in two generations. The proband was a 3-year-old boy (2:1 in Figure 1A), who was referred to the emergency unit of hospital Rajaei in Iran, due to recurrent syncope, multiple episodes of seizure and convulsion. A 12-lead electrocardiography was done. QTc interval was 560 ms (Figure 2A). The echocardiography showed normal cardiac structure. No auditory phenotype was detected in the proband. A proband’s sibling died suddenly at 16 weeks of age (2:2 in Figure 1A). The patient’s parents did not show any symptom, although they were also subjected to ECG studies.
Figure 1: Pedigrees and mutation confirmation. A: Family pedigree for the patient 1. B: DNA Sanger sequencing confirmation for c.1838C >T (p.T613M) mutation in the patient 1 with heterozygote condition (lower) and normal parents (upper and middle). C: Family pedigree for the patient 2. D: DNA Sanger sequencing confirmation for c.934A>T (p.T312S) mutation in the patient 2 with homozygote condition (lower), unaffected heterozygote parents (middle) and normal sequence (upper). SAB: Spontaneously Abortion.
Family 2 (RW): The proband (3:1 in Figure 1B) was a 15-years-old boy with a history of repeated syncopal events since the age of 2 years and seizure since the age of 9 years. He also had a history of palpitation around the age of 8 years. His QTc interval was 510 ms (Figure 2B). He showed a normal cardiac structure in the echocardiography and no auditory phenotype was detected in the proband.
Family 3 (JLNS): In this family, there were three siblings (4:5 in Figure 3A) with one deaf who was an 8-year-old boy referred because of recurrent episodes of syncope. He had a history of seizures since the age of 4.5. QTc was markedly prolonged in the index patient, 580 ms (Figure 4A). As a result of the high-risk situation, an endocardial Implantable Cardioverter Defibrillator (ICD) was implanted. Propranolol with a dose of 5 mg/kg/day, divided three times a day, was started for the patient. The Sensorineural deafness was diagnosed at 2.5 years and is managed with hearing aids. Heterozygous carrier parents had no clinical phenotype.
Figure 3: Pedigrees, haplotype analysis and mutation confirmation. A: Family pedigree for the patient 3. The results of haplotype analysis with four STR markers encompassing the KCNQ1 gene were displayed below each individual. B: Family pedigree for the patient 4 and haplotype analysis results. C: DNA Sanger sequencing confirmation for c.477+5G>A mutation in the index cases (lower), unaffected heterozygous parents (middle) and normal sequence (upper). SAB: Spontaneously Abortion
Family 4 (JLNS): The proband was a 9-year-old boy (4:6 in Figure 3B) with a history of recurrent syncope and seizures since the age of 2 years. He was deaf and had cochlear implants at 3 years. After referral to our arrhythmia clinic, an endocardial Implantable Cardioverter Defibrillator (ICD) was implanted. Propranolol was started (5 mg/kg/ day, divided three times a day), which suppressed his symptoms. The ECG of the proband showed a QTc of 560 ms (Figure 4B). The parents and his brother were without any cardiac events. Further family history was unavailable.
After obtaining informed consents and study approval by the ethics committee of the Pasteur Institute of Iran and Rajaie Cardiovascular Medical and Research Centre (adopted from the 1975 Helsinki Declaration), blood samples were collected from patients and their family members in tubes containing EDTA. Genomic DNA was isolated from the peripheral blood according to the standard salting out protocol [6,7].
Haplotype analysis for LQT1–3 (loci) was performed for the detection of related genes in such heterogeneous cardiac diseases, in the families with the utility of a set of 16 polymorphic short tandem repeat (STR) markers which including D11SD8.3, D11SU10.9, D11SU2.2, D11SU0.6, D11SD13.6 (LQT1) as described in detail by Amirian et al., D7SU7, D7SU4.8, D7SU3, D7SD5, D7SD6, D7SD9 (LQT2); and D3SU11, D3SU10.8, D3SU2.5, D3SI, D3SD5.6 (LQT3) as described in detail by Zafari et al. . All STRs which were unique were selected among penta or tetra-nucleotide repeat markers and were located upstream or downstream of the genes at a distance of less than 1.4 Mb. Size determination of the repeats was performed on ABI 3130XL Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).
The patients were screened for the pathogenic variant by Sanger sequencing. The primer pairs for all coding exons and exon-intron boundaries and untranslated regions of three common LQTS-causative genes: KCNQ1 [NM_000218], KCNH2 (NM_000238) and SCN5A (NM_198056.2) were designed by primer 3 online and gene runner software (the sequence of primers are available upon request). Exons of the three genes were amplified by PCR and the purified PCR products were sequenced with both amplification primers, forward and reversed by sanger sequencing chain termination method on ABI 3130XL Genetic Analyzer by Kawsar Biotech Co. (KBC, Tehran, Iran) .
In silico variant analysis
The novel recessive variant found in patient was interpreted by a variety of in silico predictive programs. For predicting the functional impact of the variant on the protein, MutationTaster, HSF, Mutation Assessor, SIFT, PolyPhen-2 and FATHMM were used. The secondary structure of the protein was predicted by I-TASSER server. GERP++, PhyloP and PhastCons methods were also used to predict the conservation score [10-17].
Family and population study
Genealogy and co-segregation analyses were performed for all members of the family with available DNA samples for the novel missense variant. A total of 100 unrelated healthy individuals with the same ethnicity were collected to detect the genotype by amplification refractory mutation system (ARMS) PCR for the identified variant c.934A>T in the population.
Family 1 (RWS): Genetic screening showed the absence of mutation in SCN5A and KCNQ1 genes in either the proband or the parents. However, the sequencing analysis of the KCNH2 gene in the proband revealed a de novo heterozygous single-nucleotide substitution; c.1838C>T in exon 7 of the KCNH2 gene, which creates a nonsynonymous change (p.T613M) (Figure 1C). De novo mutation in LQTS was previously reported for human HERG gene . Paternity test based on microsatellite repeat length (VNTR) and RFLP analysis excluded any non-paternity/non-maternity. Additionally, haplotype analysis showed his parents shared the same haplotype (data not shown). This suggests that the C>T change in codon 613 of the KCNH2 gene in the proband is either a de novo mutation in the proband or a germ line mosaic mutation in the parent.
Family 2 (RWS): Bidirectional Sanger sequencing revealed that a novel homozygous missense KCNQ1 gene variant c.934A>T (ClinVar accession number: SCV000700208) resulted in Threonine to Serine substitution at position 312 (p.T312S) (Figure 1D). The variant was neither reported in 1000 Genome nor Exome Aggregation Consortium (ExAC) and was absent in 200 control alleles in the normal population. The proband shared the same haplotype in the parent (data not shown) and cosegregation analysis confirmed that the variant was associated with LQTS. The p.T312S variant identified in this study has not been reported previously. The predictive software (Phylop, PhastCons and GERP++) determined that the Threonine 312 position on the KCNQ1 channel is evolutionary conserved (Table 1). The secondary structure for the Threonine 312 in the natural protein was identified as a coil structure by I-TASSER server with an almost high confidence value (Figure 5).
|S. no||Predictive Software||Prediction||Score|
|3||Mutation Taster||Protein features (might be) affected Splice site changes||0.98|
|5||SNPs and GO||Disease||7|
|7||HSF||Alteration of an Exonic ESE site Potential alteration of Splicing||-|
Table 1: In silico analysis results for the variant p.T312S.
Family 3, 4 (JLNS): Haplotype analysis encompassing the three candidate genes showed homozygosity of the STR markers around the KCNQ1 gene in two JLNS index cases (Figure 4). This resulted to evaluation of the KCNQ1 gene in these families. During DNA sequence analysis of the candidate gene, a single, homozygous nucleotide substitution c.477+5G>A was detected in the KCNQ1 gene of the two JLNS probands (Figure 3C). The mutation was found in heterozygous form in the parents (3:1 and 3:2 in Figure 4A and 3:4 and 3:5 in Figure 3B), and also in the other living sister and brother of patient 3 and patient 4, respectively (4:4 in Figure 3A and 4:5 in Figure 3B). This sequence change that resulted to a splice site alteration in intron 2 of the gene has already been reported as pathogenic in the literature . Likewise splice site prediction tools interpreted this splice variant to be pathogenic due to disruption of probable splicing donor site.
In the present study KCNQ1, KCNH2, and SCN5A genes were screened in four Iranian families among a cohort of 31 unrelated LQTS patients. A de novo heterozygous missense mutation in exon 7 of the KCNH2 gene was detected in a RW patient and a novel homozygous missense KCNQ1 gene variant in another RW patient. JLNS patients in two families had homozygous splice site mutation in the KCNQ1 gene. In LQTS type2 (KCNH2) and type3 (SCN5A) with autosomal dominant inheritance pattern, and catecholaminergic polymorphic ventricular tachycardia (CPVT)(RYR2), de novo mutations occur frequently [20- 22]. The c.1838C>T substitution has previously been reported in Japan, Netherlands, and USA in association with LQTS patients and in a fetus with prenatal diagnosis of LQTS by fast next generation sequencing [23-25]. This is the first time that the same mutation with a de novo pattern was found in an Iranian family. Similar variant (p.T613A) affecting the same residues have been identified in association with Long QT syndrome . Hence, it is possible that the variant detected in this study is more likely pathogenic with a similar effect. Additionally, mutation c.1838 C> T is located in a CpG sequence in the pore helix of the Kv11.1 protein between S5 and S6 potassium channel domains in which common missense mutations such as Y611H, V612L, T613A, and A614V are frequently reported [18,26]. Physiological studies have revealed that p.T613M mutation inhibited normal trafficking of the HERG protein to the surface membrane and caused a loss of function as well as a decrease in cell surface protein . The majority of HERG mutations, more than 200 reported, have loss of function mechanism; which is, a considerable decrease of the protein product caused by the mutated allele . In concordance with the genetic study result, our patient showed the clinical features of seizure, recurrent episodes of syncope and the family history of serious heart events such as sudden cardiac death in the sibling of the proband (2:2 in Figure 3A) who died at 16 weeks of age.
A new homozygous missense KCNQ1 gene variant (p.T312S) was identified in the pore region of the human cardiac potassium channel of a RW family. The mutation causes a substitution from threonine to serine, which is well known for its ability to disrupt the secondary structure of the protein. Threonine 312 is located in the extracellular loop of the pore forming within a coil structure which is evolutionary conserved in mammals. The pathogenicity of Threonine substitution at codon 312 with Serine as a novel variant was predicted using all the online predictive tools (Table 1). Additionally, the occurrence of a missense variant in the pore forming alpha subunit of the KCNQ1 protein is expected to be likely pathogenic with an estimated predicted value (EPV) of 94% . Based on previous reports disruption in the pore region of KCNQ1 and KCNH2 in RW families because of full lossof- function of potassium channels Kv7.1 and Kv11.1could lead to a severe LQTS phenotype [23,29]. Since the recessive mutation did not detect in 200 normal chromosomes, ruled out a typical polymorphism. Overall, according to the American College of Medical Genetics and Genomics guidelines the recessive KCNQ1 variant is classified as a likely pathogenic variant . The clinical manifestations of the prolonged QT interval of about 510 ms, recurrent episodes of syncope, palpitation and seizure were in concordance with the molecular testing result of the patient. The family history of cardiac events such as fainting in the proband's mother and convulsion episodes in family members has also been presented. This finding indicates that along with clinical evaluations, genetic testing should be done for detection of family members who are at risk.
An intronic homozygous mutation was detected in the splice regulatory site at intron 2 of the KCNQ1 gene in two children from two unlinked families which co-segregate with the LQT1-JLNS phenotype. It is important to emphasize that as a given LQTS-associated variant, the variant must have involved a conserved amino acid or splice site that change the primary structure of the encoded protein . As described in previous studies from Iran [9,31], although JLNS causing mutations in KCNQ1 are mostly truncating and result in complete abolishment of IKs channel function . but intronic mutations also besides frameshift mutation lead to full skipping of KCNQ1, thereby causing transcriptional deviance. For preservation of hearing, IKs channel is required for K+ conduction in the inner ear endolymph. Homozygous or compound heterozygous mutations of KvLQTl result to complete loss of IKs function, insufficient endolymph production, decadence of Corti organ, and consequently sensorineural deafness . Functional analysis with the splice mutant KCNQ1 channel revealed that there was no recognizable IKs current, which is concurrent with the hearing loss . Both homozygous carriers from two unrelated families as a true JLNS phenotype experienced severe cardiac arrhythmias with considerably prolonged QTc and deep congenital neural deafness. Both patients had their first episode of syncope before the age of 2. This splice mutation is associated with a high risk of sudden death if untreated.
Altogether, in our cohort, two LQTS missense mutations and one splice site KCNQ1 mutation were identified in four index cases in our cardiogenetic clinic in Iran. This indicates that the prevalence of LQTS is indubitably much higher in Iran than what is expected as a result, which exigencies a widespread observation in this country. Further, in the current study a novel recessive mutation in an AR-RWS patient was found for the first time in the Iranian population. Till date, only one report of mutation screening in four AR-RWS patients of Iranian origin has been described and the current study adds to this slight literature . This study helps the development of genetic testing for arrhythmia susceptibility. Finally, mutation identification is of importance for presymptomatic diagnosis and treatment, in some cases.
This work was supported by Pasteur Institute of Iran (grant number 824 partly and the Ph.D. grant from education office, Pasteur Institute of Iran). We acknowledge the efforts of referring clinicians. We are indebted to the patients and family members for their participation.
Conflict of Interests
None of the authors have any conflict of interests with regard to this publication.
- Schwartz PJ, Ackerman MJ (2013) The long QT syndrome: A transatlantic clinical approach to diagnosis and therapy. Eur Heart J 34: 3109-3116.
- Zhang L, Timothy KW, Vincent GM, Lehmann MH, Fox J, et al. (2000) Spectrum of ST-T–wave patterns and repolarization parameters in congenital long-QT syndrome. Circulation 102: 2849-2855.
- Mizusawa Y, Horie M, Wilde AA (2014) Genetic and clinical advances in congenital long QT syndrome. Circ J 78: 2827-2833.
- Schwartz PJ, Crotti L, Insolia R (2012) Long-QT syndrome. Circulation: Arrhythmia and Electrophysiol 5: 868-877.
- Reed GJ, Boczek NJ, Etheridge S, Ackerman MJ (2015) CALM3 mutation associated with long QT syndrome. Heart Rhyth 12: 419.
- Tester DJ, Ackerman MJ (2014) Genetics of long QT syndrome. Method DeBakey Cardiovasc J 10: 29.
- Chacon-Cortes D, Griffiths LR (2014) Methods for extracting genomic DNA from whole blood samples: current perspectives. J Biorepos Sci Appl Med 1: 1-9.
- Zafari Z, Amirian A, Nejad FR, Akbari V, Akbari MT, et al. (2018) Development and diversity of a novel panel of short tandem repeat markers encompassing the SCN5A gene in Iranian population. J Genet 1: 1-4.
- Amirian A, Dalili SM, Zafari Z, Saber S, Karimipour M, et al. (2018) Novel frameshift mutation in the KCNQ1 gene responsible for Jervell and Lange-Nielsen syndrome. Iranian J Basic Med Sci 21: 108- 111.
- Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) Mutation Taster2: Mutation prediction for the deep-sequencing age. Nature Methods 11: 361.
- Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, et al. (2009) Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37: e67-e67.
- Reva B, Antipin Y, Sander C (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 39: e118-e118.
- Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature Protocols 4: 1073.
- Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen‐2. Curr Protocols Hum Genet 7: 21-27.
- Shihab HA, Gough J, Cooper DN, Stenson PD, Barker GL, et al. (2013) Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat 34: 57-65.
- Yang J, Yan R, Roy A, Xu D, Poisson J, et al. (2015) The I-TASSER Suite: Protein structure and function prediction. Nature Methods 12: 7.
- Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, et al. (2010) Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comp Biol 6: e1001025.
- Jongbloed R, Wilde A, Geelen J, Doevendans P, Schaap C, et al. (1999) Novel KCNQ1 and HERG missense mutations in Dutch long-QT families. Hum Mutat 13: 301.
- Tester DJ, Will ML, Haglund CM, Ackerman MJ (2005) Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2: 507-517.
- Beery TA, Shooner KA, Benson DW (2007) Neonatal long QT syndrome due to a de novo dominant negative hERG mutation. Am J Crit Care 16: 416-412.
- Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, et al. (2009) The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: A comprehensive open reading frame mutational analysis. J Am Coll Cardiol 54: 2065-2074.
- Wedekind H, Smits JP, Schulze-Bahr E, Arnold R, Veldkamp MW, et al. (2001) De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 104: 1158-1164.
- Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, et al. (2009) Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 54: 2052-2062.
- Huang FD, Chen J, Lin M, Keating MT, Sanguinetti MC (2001) Long-QT syndrome-associated missense mutations in the pore helix of the HERG potassium channel. Circulation 104: 1071-1075.
- Priest JR, Ceresnak SR, Dewey FE, Malloy-Walton LE, Dunn K, et al. (2014) Molecular diagnosis of long QT syndrome at 10 days of life by rapid whole genome sequencing. Heart Rhythm 11: 1707-1713.
- Satler CA, Vesely MR, Duggal P, Ginsburg GS, Beggs AH (1998) Multiple different missense mutations in the pore region of HERG in patients with long QT syndrome. Hum Genet 102: 265-272.
- Lees-Miller JP, Duan Y, Teng GQ, Thorstad K, Duff HJ (2000) Novel gain-of-function mechanism in K+ channel–related long-QT syndrome: Altered gating and selectivity in the HERG1 N629D mutant. Circul Res 86: 507-513.
- Giudicessi JR, Ackerman MJ (2013) Genotype-and phenotype-guided management of congenital long QT syndrome. Curr Prob Cardiol 38: 417-455.
- Zareba W, Moss AJ, Sheu G, Kaufman ES, Priori S, et al. (2003) Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome. J Cardiovas Electrophysiol 14: 1149-1153.
- Richards S, Aziz N, Bale S, Bick D, Das S, et al. (2015) Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17: 405.
- Amirian A, Zafari Z, Dalili M, Saber S, Karimipoor M, et al. (2018) Detection of a new KCNQ 1 frameshift mutation associated with Jervell and Lange‐Nielsen syndrome in 2 Iranian families. J Arrhythmia 34: 286-290.
- Wollnik B, Schroeder BC, Kubisch C, Esperer HD, Wieacker P, et al. (1997) Pathophysiological mechanisms of dominant and recessive KVLQT1 K+ channel mutations found in inherited cardiac arrhythmias. Hum Mol Genet 6: 1943-1949.
- Sanguinetti MC (2000) Long QT syndrome. J Cardiovas Electrophysiol 11: 710-712.
- Wangemann P (2002) K+ cycling and its regulation in the cochlea and the vestibular labyrinth. Audiol Neurotol 7: 199-205.
- Zafari Z, Saber S, Zeinali S, Dalili M, Fazelifar AF, et al. (2017) Identification and characterization of a novel recessive KCNQ1 mutation associated with Romano-Ward Long-QT syndrome in two Iranian families. J Electrocardiol 50: 912-918.
Citation: Amirian A, Karimipoor M, Zafari Z, Kallhor M, Dalili M, et al. (2018) Molecular Analysis of KCNQ1, KCNH2 and SCN5A Genes in Iranian Patients with Long QT Syndrome. J Mol Genet Med 12: 359 DOI: 10.4172/1747-0862.1000359
Copyright: ©2018 Amirian A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
11th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics
Oct 23-24, 2019 Amsterdam, Netherlands
November 11-12, 2019 Amsterdam, Netherlands
December 16-17, 2019 Dubai, UAE
- Total views: 996
- [From(publication date): 0-0 - Oct 23, 2019]
- Breakdown by view type
- HTML page views: 947
- PDF downloads: 49